The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2.
about
Ex vivo screening for immunodominant viral epitopes by quantitative real time polymerase chain reaction (qRT-PCR)Cross-Allele Cytotoxic T Lymphocyte Responses against 2009 Pandemic H1N1 Influenza A Virus among HLA-A24 and HLA-A3 Supertype-Positive IndividualsHuman cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virusDiverse heterologous primary infections radically alter immunodominance hierarchies and clinical outcomes following H7N9 influenza challenge in miceImmunity to seasonal and pandemic influenza A virusesHarmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine ConsortiumAn HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteinsFunctional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation.Targeting p53 as a general tumor antigen.Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination.Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons.Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytesIdentification of novel avian influenza virus derived CD8+ T-cell epitopesChagasic patients are able to respond against a viral antigen from influenza virus.Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatographyBreast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptideAn anti-PR1/HLA-A2 T-cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells.Respiratory syncytial virus nucleoprotein-specific cytotoxic T-cell epitopes in a South African population of diverse HLA types are conserved in circulating field strains.Decline of influenza-specific CD8+ T cell repertoire in healthy geriatric donors.Cross-reactivity and expansion of dengue-specific T cells during acute primary and secondary infections in humans.Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human blood.Identification of Immunodominant Responses to the Plasmodium falciparum Antigens PfUIS3, PfLSA1 and PfLSAP2 in Multiple Strains of MiceThe polyclonal CD8 T cell response to influenza M158-66 generates a fully connected network of cross-reactive clonotypes to structurally related peptides: a paradigm for memory repertoire coverage of novel epitopes or escape mutantsT-cell libraries allow simple parallel generation of multiple peptide-specific human T-cell clones.The human side of influenza.Human melanoma-specific CD8(+) T-cells from metastases are capable of antigen-specific degranulation and cytolysis directly ex vivo.Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment.Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines.Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patientsExpansion of quiescent lung adenocarcinoma CD8+ T cells by MUC1-8-mer peptide-T2 cell-β2 microglobulin complexesA HCMV pp65 polypeptide promotes the expansion of CD4+ and CD8+ T cells across a wide range of HLA specificities.Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccineProtective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashionHLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides.Evasion of influenza A viruses from innate and adaptive immune responses.Marked enhancement of the antigen-specific immune response by combining plasmid DNA-based immunization with a Schiff base-forming drugThe magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis.Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8.
P2860
Q24791836-750FE9EE-B1AC-4560-97E0-1BDD9E9EA29EQ27673689-9015B7F1-B2B0-4C90-8A01-0D079D47BF16Q30355817-EB263AD3-56A5-452F-AC93-E256B70EC62EQ30371622-ECA3E1B5-DF4B-4C01-B40B-DB0E19115D3FQ30399357-4FB8E294-1F55-4359-B2DD-8EDA2C22B6F9Q30439109-3F33BCC1-6569-48AB-9FD6-EEC6DA4BE3B4Q30442847-6594F8DB-BB26-48F4-AB04-10BB8A1469A2Q33482103-42DAE7ED-291D-4F1C-AC42-EF8CB5708C47Q33638172-0266982B-C983-40C3-87AF-CC3E85E9F10CQ33825567-7A1780F9-07C8-47F8-B208-697A8B362627Q33835126-8227FDA8-5C64-4CC9-8155-933CA8D5A917Q33930372-26E3DF4E-4FA8-4088-8CB7-AB3F50D598B9Q34182121-F3EA8B54-FCB0-4ED5-A293-1A606CADE1DFQ34392873-1698014A-DABC-4D49-A5EB-4288008DF8ECQ34722878-3A0EE37C-76A9-47BC-AB79-96182C45192EQ34765735-06E997B7-06B6-4C96-AC15-2A40BC21899AQ34923734-85C771C8-5C3F-4FDE-ABC8-C4A9489925F9Q35149956-58DEC1BC-8D89-4395-B7D1-FCA6434AC059Q35230365-74DF7D9D-45F7-456C-9527-D0E98DF7F90EQ35551374-C83EE1F0-4F4D-4F50-849A-D46BC3F6C241Q35731386-C80A32DB-84AD-4061-B4D2-9CB5A16D9404Q35867348-0F18A2C8-35C7-4B35-9B45-FDF7818976B5Q35885509-6FD18B0A-4819-4372-87A7-C7E7A2A04A4AQ35908845-ACD703FB-932E-4BF1-97A3-AC9EA60DAD9BQ36055988-20945CA8-1BDA-4CD7-85B9-7184DFBEFF3CQ36057468-6987CD38-8778-4B7D-A9B8-172578F0A46BQ36364315-7D7C3FEB-29D5-4317-83C3-1079BFC7C789Q36364998-94F33D08-00CE-4DBC-BF5E-F8F7A92036BEQ36399737-DC07EB2D-8F62-40DE-A01E-490C361A7F07Q36425747-86FE86C2-B2D6-4BAE-92AB-9BC85B5D4792Q36547317-AFCEEA63-F9BB-49C6-98FD-F3A9DB107548Q36633526-A7BC1625-E5C8-4D41-8FC7-16A278B04DA7Q36829259-9BBCDDB1-A1A8-4659-A488-E8412A0DD936Q36954248-A6EC1F0B-3319-412B-871D-2E7163537886Q37424484-29212BB4-C5E1-453B-9C85-7001EB68D74DQ38061423-71B5B5BA-8F29-4E9A-BBE4-BFD7C63845DBQ39672052-2794A538-0BCA-449A-B309-87A2D97AB9C2Q39685999-BC307100-EE84-46EC-AE91-8BA89E198D14Q39787946-F17A869B-9208-4970-9842-A7636C8E5463Q40720422-1AD5D2C4-18C1-4CBB-8E15-5B04B6253653
P2860
The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
The minimum peptide epitope fr ...... tracellular loading of HLA-A2.
@en
The minimum peptide epitope fr ...... tracellular loading of HLA-A2.
@nl
type
label
The minimum peptide epitope fr ...... tracellular loading of HLA-A2.
@en
The minimum peptide epitope fr ...... tracellular loading of HLA-A2.
@nl
prefLabel
The minimum peptide epitope fr ...... tracellular loading of HLA-A2.
@en
The minimum peptide epitope fr ...... tracellular loading of HLA-A2.
@nl
P2093
P1476
The minimum peptide epitope fr ...... tracellular loading of HLA-A2.
@en
P2093
Bednarek MA
Tamhankar S
Williamson AR
Zweerink HJ
P304
P407
P577
1991-12-01T00:00:00Z